Purchasing Implantable Medical Devices in Egypt Using a Multicriteria Decision Analysis (MCDA) Tool

Author(s)

Elezbawy B1, Fasseeh AN2, Németh B3, Roushdy M4, Eldebeiky M5, Refaat R5, Taha A5, Rabiea S6, Abdallah M7, Ramadan S8, Ibrahim A9, Noaman H10, Bahaa Eldin A10, Mostafa H6, Nouh S5, Zaki A11, Abdelrahman M9, Abaza S12, Kalo Z13
1Syreon Middle East, Alexandria, Egypt, 2a)Syreon Middle East; b)Eötvös Loránd University, Budapest, Alexandria, Egypt, 3Syreon Research Institute, Budapest, Hungary, 4The Egyptian Authority for Unified Procurement "UPA", Cairo, Egypt, 5The Egyptian Authority for Unified Procurement "UPA", Cairo, C, Egypt, 6Ministry of Health and Population, Cairo, Egypt, 7Suez Canal University Hospital, Ismailia, Egypt, 8Zagazig University, Zagazig, Egypt, 9Egyptian Drug Authority, Cairo, Egypt, 10Health Insurance Organization, Cairo, Egypt, 1110. The General Authority of Health care, Cairo, Egypt, 12Syreon Middle East, Cairo, C, Egypt, 131) Semmelweis University; 2) Syreon Research Institute, Budapest, PE, Hungary

OBJECTIVES: Multicriteria decision analysis tools are tools that capture the attributes of specific products and compare them to provide an objective method for choosing among the available options. In Egypt, there are several implantable medical devices with different specifications. Choosing the most efficient tool to reimburse between those is not always an easy task. We aimed to create an objective tool to choose the best device among the available implantable medical devices for reimbursement.

METHODS: To identify relevant criteria, a systematic literature review and expert interviews were conducted. Then experts in procurement and tendering chose the criteria, ranked them, assigned weights, defined scoring functions for each criterion and created the draft tool during a workshop. The draft tool was used in a pilot phase, then another workshop was conducted to fine tune the tool. The tool readjusted based on the experts’ experience with the draft tool.

RESULTS: Experts agreed to include 8 criteria in the final tool. These were: technical characteristics of the medical device (29.4% of the weight), country of origin (19.5%), use in reference countries (14.9%), supply reliability (11.7%), previous use in tenders (9.0%), instant replacement within product variety (6.9%), pharmacovigilance system (4.6%) and refund or replacement (4.0%). The tool assesses the devices for the 8 criteria and the device that achieves the highest final is considered the best. Price was not included in the MCDA tool, and it will be added in the financial evaluation phase.

CONCLUSIONS: The MCDA tool can help decisionmakers take evidence-based decisions concerning purchasing implantable devices for the public sector in Egypt. The tool compares the available options, and provides a summary score for each, then the decision is much easier and more transparent. The price is then evaluated and the product with the best value is chosen for reimbursement.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

HTA16

Topic

Health Policy & Regulatory, Health Technology Assessment, Medical Technologies, Study Approaches

Topic Subcategory

Medical Devices, Public Spending & National Health Expenditures, Surveys & Expert Panels, Value Frameworks & Dossier Format

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×